biohack.The longevity wire
LIVE WIREUpdated · scanning every 6 hours
11:36 Women on menopause hormones lost a bit more weight on Ozempic-style drugs✦05:37 Sugar found mostly in red meat tied to higher diabetes risk in early study✦05:34 AI readings of heart MRIs slightly beat doctors at flagging death risk✦11:39 Breast cancer drug shrank tumors in 5 of 10 after Enhertu, makers say✦05:35 Drugmaker asks FDA to test a new shot for advanced dry macular degeneration✦23:41 Top OB-GYN group updates hot-flash advice for first time in 12 years✦23:39 Blood proteins tied to menopause may hint at women's later dementia risk✦23:36 Earlier heart valve fix cut heart failure events in some older adults✦11:36 Women on menopause hormones lost a bit more weight on Ozempic-style drugs✦05:37 Sugar found mostly in red meat tied to higher diabetes risk in early study✦05:34 AI readings of heart MRIs slightly beat doctors at flagging death risk✦11:39 Breast cancer drug shrank tumors in 5 of 10 after Enhertu, makers say✦05:35 Drugmaker asks FDA to test a new shot for advanced dry macular degeneration✦23:41 Top OB-GYN group updates hot-flash advice for first time in 12 years✦23:39 Blood proteins tied to menopause may hint at women's later dementia risk✦23:36 Earlier heart valve fix cut heart failure events in some older adults
← All story threadsSTORY THREAD

Breast cancer drug for after Enhertu stops working.

1 report so far. New developments are added to this thread as they happen.

  1. Nov 2, 2026
    TUMORS SHRANK IN 5 OF 10 EARLY PATIENTSCompany results · 10 patients

    Breast cancer drug shrank tumors in 5 of 10 after Enhertu, makers say

    An early test of a targeted drug carrying a different cell-killing cargo shrank tumors in half of 10 heavily treated HER2-positive breast cancer patients who had already received Enhertu.